Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1151

1.

Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo.

Lee SH, McIntyre D, Honess D, Hulikova A, Pacheco-Torres J, Cerdán S, Swietach P, Harris AL, Griffiths JR.

Br J Cancer. 2018 Sep 12. doi: 10.1038/s41416-018-0216-5. [Epub ahead of print]

PMID:
30206370
2.

Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.

Sly JR, Harris AL.

Nurs Womens Health. 2018 Aug 23. pii: S1751-4851(18)30169-7. doi: 10.1016/j.nwh.2018.07.004. [Epub ahead of print]

PMID:
30145235
3.

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.

Tsoukalas C, Psimadas D, Kastis GA, Koutoulidis V, Harris AL, Paravatou-Petsotas M, Karageorgou M, Furenlid LR, Moulopoulos LA, Stamopoulos D, Bouziotis P.

Front Chem. 2018 Jun 20;6:224. doi: 10.3389/fchem.2018.00224. eCollection 2018.

4.

Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases.

Kannan P, Kretzschmar WW, Winter H, Warren D, Bates R, Allen PD, Syed N, Irving B, Papiez BW, Kaeppler J, Markelc B, Kinchesh P, Gilchrist S, Smart S, Schnabel JA, Maughan T, Harris AL, Muschel RJ, Partridge M, Sharma RA, Kersemans V.

Clin Cancer Res. 2018 Jun 29. doi: 10.1158/1078-0432.CCR-18-0033. [Epub ahead of print]

PMID:
29959141
5.

The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.

Leithner K, Triebl A, Trötzmüller M, Hinteregger B, Leko P, Wieser BI, Grasmann G, Bertsch AL, Züllig T, Stacher E, Valli A, Prassl R, Olschewski A, Harris AL, Köfeler HC, Olschewski H, Hrzenjak A.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6225-6230. doi: 10.1073/pnas.1719871115. Epub 2018 May 29.

6.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 May 15. doi: 10.1007/s10456-018-9613-x. [Epub ahead of print] Review.

7.

Whole Exome Sequencing and Molecular Modeling of a Missense Variant in TNFAIP3 That Segregates with Disease in a Family with Chronic Urticaria and Angioedema.

Harris AL, Blackburn PR, Richter JE Jr, Gass JM, Caulfield TR, Mohammad AN, Atwal PS.

Case Rep Genet. 2018 Feb 22;2018:6968395. doi: 10.1155/2018/6968395. eCollection 2018.

8.

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma.

Harris AL, Lee SE, Dawson LK, Marlow LA, Edenfield BH, Durham WF, Flotte TJ, Thompson M, Small DL, Synnott AJ, Markovic SN, Copland JA.

Oncotarget. 2017 Dec 23;9(13):10905-10919. doi: 10.18632/oncotarget.23649. eCollection 2018 Feb 16.

9.

Non-angiogenic tumours and their influence on cancer biology.

Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, Harris AL, Pezzella F.

Nat Rev Cancer. 2018 May;18(5):323-336. doi: 10.1038/nrc.2018.14. Epub 2018 Mar 9. Review.

PMID:
29520090
10.

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.

Woodcock VK, Clive S, Wilson RH, Coyle VM, Stratford MRL, Folkes LK, Eastell R, Barton C, Jones P, Kazmi-Stokes S, Turner H, Halford S, Harris AL, Middleton MR.

Br J Cancer. 2018 Mar 20;118(6):770-776. doi: 10.1038/bjc.2017.484. Epub 2018 Feb 13.

11.

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.

Earwaker P, Anderson C, Willenbrock F, Harris AL, Protheroe AS, Macaulay VM.

PLoS One. 2018 Feb 1;13(2):e0191890. doi: 10.1371/journal.pone.0191890. eCollection 2018.

12.

SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy.

Koukourakis MI, Giatromanolaki A, Fylaktakidou K, Sivridis E, Zois CE, Kalamida D, Mitrakas A, Pouliliou S, Karagounis IV, Simopoulos K, Ferguson DJP, Harris AL.

Invest New Drugs. 2018 Oct;36(5):773-781. doi: 10.1007/s10637-018-0566-0. Epub 2018 Jan 31.

PMID:
29387992
13.

Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer.

Yang J, Harris AL, Davidoff AM.

Int J Mol Sci. 2018 Jan 13;19(1). pii: E240. doi: 10.3390/ijms19010240. Review.

14.

Amifostine Protects Mouse Liver Against Radiation-induced Autophagy Blockage.

Koukourakis MI, Giatromanolaki A, Fylaktakidou K, Kouroupi M, Sivridis E, Zois CE, Kalamida D, Mitrakas A, Pouliliou S, Karagounis IV, Simopoulos K, Ferguson DJP, Harris AL.

Anticancer Res. 2018 Jan;38(1):227-238.

PMID:
29277777
15.

miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense.

Pajic M, Froio D, Daly S, Doculara L, Millar E, Graham PH, Drury A, Steinmann A, de Bock CE, Boulghourjian A, Zaratzian A, Carroll S, Toohey J, O'Toole SA, Harris AL, Buffa FM, Gee HE, Hollway GE, Molloy TJ.

Cancer Res. 2018 Jan 15;78(2):501-515. doi: 10.1158/0008-5472.CAN-16-3105. Epub 2017 Nov 27.

PMID:
29180477
16.

Single-cell heterogeneity in ductal carcinoma in situ of breast.

Gerdes MJ, Gökmen-Polar Y, Sui Y, Pang AS, LaPlante N, Harris AL, Tan PH, Ginty F, Badve SS.

Mod Pathol. 2018 Mar;31(3):406-417. doi: 10.1038/modpathol.2017.143. Epub 2017 Nov 17.

PMID:
29148540
17.

Advances in Hypoxia-Inducible Factor Biology.

Choudhry H, Harris AL.

Cell Metab. 2018 Feb 6;27(2):281-298. doi: 10.1016/j.cmet.2017.10.005. Epub 2017 Nov 9. Review.

PMID:
29129785
18.

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.

Milani M, Venturini S, Bonardi S, Allevi G, Strina C, Cappelletti MR, Corona SP, Aguggini S, Bottini A, Berruti A, Jubb A, Campo L, Harris AL, Gatter K, Fox SB, Generali D, Roviello G.

Oncotarget. 2017 Aug 14;8(45):78870-78881. doi: 10.18632/oncotarget.20239. eCollection 2017 Oct 3.

19.

Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.

Morotti M, Dass PH, Harris AL, Lord S.

Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):137-153. doi: 10.1007/s13318-017-0442-x. Review.

PMID:
29019020
20.

PrEP awareness and decision-making for Latino MSM in San Antonio, Texas.

García M, Harris AL.

PLoS One. 2017 Sep 27;12(9):e0184014. doi: 10.1371/journal.pone.0184014. eCollection 2017.

21.

The evaluation of extraction techniques for Tetranychus urticae (Acari: Tetranychidae) from apple (Malus domestica) and cherry (Prunus avium) leaves.

Harris AL, Ullah R, Fountain MT.

Exp Appl Acarol. 2017 Aug;72(4):367-377. doi: 10.1007/s10493-017-0154-6. Epub 2017 Aug 22.

PMID:
28831615
22.

Intramolecular signaling in a cardiac connexin: Role of cytoplasmic domain dimerization.

Trease AJ, Capuccino JMV, Contreras J, Harris AL, Sorgen PL.

J Mol Cell Cardiol. 2017 Oct;111:69-80. doi: 10.1016/j.yjmcc.2017.07.010. Epub 2017 Jul 25.

PMID:
28754342
23.

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.

Abu-Jamous B, Buffa FM, Harris AL, Nandi AK.

Mol Cancer. 2017 Jun 15;16(1):105. doi: 10.1186/s12943-017-0673-0.

24.

Assessing Marijuana Use During Pregnancy.

Harris AL, Okorie CS.

Nurs Womens Health. 2017 Jun - Jul;21(3):207-216. doi: 10.1016/j.nwh.2017.04.001.

PMID:
28599742
25.

Genomic instability induced in distant progeny of bystander cells depends on the connexins expressed in the irradiated cells.

de Toledo SM, Buonanno M, Harris AL, Azzam EI.

Int J Radiat Biol. 2017 Oct;93(10):1182-1194. doi: 10.1080/09553002.2017.1334980. Epub 2017 Jun 15.

PMID:
28565963
26.

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab.

Patel N, Able S, Allen D, Fokas E, Cornelissen B, Gleeson FV, Harris AL, Vallis KA.

EJNMMI Res. 2017 Dec;7(1):49. doi: 10.1186/s13550-017-0297-9. Epub 2017 May 30.

27.

Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.

Dos Santos SN, Sheldon H, Pereira JX, Paluch C, Bridges EM, El-Cheikh MC, Harris AL, Bernardes ES.

Oncotarget. 2017 Jul 25;8(30):49484-49501. doi: 10.18632/oncotarget.17718.

28.

Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.

Zhao Y, Lai Y, Ge H, Guo Y, Feng X, Song J, Wang Q, Fan L, Peng Y, Cao M, Harris AL, Wang X, Tao L.

Cell Death Dis. 2017 May 11;8(5):e2773. doi: 10.1038/cddis.2017.183.

29.

Endothelial cAMP deactivates ischemia-reperfusion-induced microvascular hyperpermeability via Rap1-mediated mechanisms.

Korayem AH, Mujica PE, Aramoto H, Durán RG, Nepali PR, Kim DD, Harris AL, Sánchez FA, Durán WN.

Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H179-H189. doi: 10.1152/ajpheart.00002.2017. Epub 2017 May 5.

30.

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.

Oon CE, Bridges E, Sheldon H, Sainson RCA, Jubb A, Turley H, Leek R, Buffa F, Harris AL, Li JL.

Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969.

31.

LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice.

Powell DR, Smith MG, Doree DD, Harris AL, Greer J, DaCosta CM, Thompson A, Jeter-Jones S, Xiong W, Carson KG, Goodwin NC, Harrison BA, Rawlins DB, Strobel ED, Gopinathan S, Wilson A, Mseeh F, Zambrowicz B, Ding ZM.

J Pharmacol Exp Ther. 2017 Jul;362(1):85-97. doi: 10.1124/jpet.117.240820. Epub 2017 Apr 25.

32.

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.

Yang L, Taylor J, Eustace A, Irlam JJ, Denley H, Hoskin PJ, Alsner J, Buffa FM, Harris AL, Choudhury A, West CML.

Clin Cancer Res. 2017 Aug 15;23(16):4761-4768. doi: 10.1158/1078-0432.CCR-17-0038. Epub 2017 Apr 11.

33.

A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1.

Erdal E, Haider S, Rehwinkel J, Harris AL, McHugh PJ.

Genes Dev. 2017 Feb 15;31(4):353-369. doi: 10.1101/gad.289769.116. Epub 2017 Mar 9.

34.

miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration.

Khoo CP, Roubelakis MG, Schrader JB, Tsaknakis G, Konietzny R, Kessler B, Harris AL, Watt SM.

Sci Rep. 2017 Mar 9;7:44137. doi: 10.1038/srep44137.

35.

Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes.

Goodwin NC, Ding ZM, Harrison BA, Strobel ED, Harris AL, Smith M, Thompson AY, Xiong W, Mseeh F, Bruce DJ, Diaz D, Gopinathan S, Li L, O'Neill E, Thiel M, Wilson AG, Carson KG, Powell DR, Rawlins DB.

J Med Chem. 2017 Jan 26;60(2):710-721. doi: 10.1021/acs.jmedchem.6b01541. Epub 2017 Jan 17.

PMID:
28045524
36.

Barriers to and Facilitators of Perinatal Depression Screening.

Harris AL.

Nurs Womens Health. 2017 Dec 2016 - Jan;20(6):601-607. doi: 10.1016/j.nwh.2016.10.004.

PMID:
27938800
37.

Confusion about HPV and Cervical Cancer Among Black/African-American Women Living with HIV.

Champman CL, Harris AL, Enah C.

J Natl Black Nurses Assoc. 2016 Dec;27(2):20-25.

PMID:
29932592
38.

MEF2 transcription factors are key regulators of sprouting angiogenesis.

Sacilotto N, Chouliaras KM, Nikitenko LL, Lu YW, Fritzsche M, Wallace MD, Nornes S, García-Moreno F, Payne S, Bridges E, Liu K, Biggs D, Ratnayaka I, Herbert SP, Molnár Z, Harris AL, Davies B, Bond GL, Bou-Gharios G, Schwarz JJ, De Val S.

Genes Dev. 2016 Oct 15;30(20):2297-2309.

39.

Mechanism of gating by calcium in connexin hemichannels.

Lopez W, Ramachandran J, Alsamarah A, Luo Y, Harris AL, Contreras JE.

Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7986-E7995. Epub 2016 Nov 21.

40.

Bifurcation transitions in gap-junction-coupled neurons.

Shaffer A, Harris AL, Follmann R, Rosa E.

Phys Rev E. 2016 Oct;94(4-1):042301. Epub 2016 Oct 3.

PMID:
27841500
41.

O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.

Santos SN, Junqueira MS, Francisco G, Vilanova M, Magalhães A, Dias Baruffi M, Chammas R, Harris AL, Reis CA, Bernardes ES.

Oncotarget. 2016 Dec 13;7(50):83570-83587. doi: 10.18632/oncotarget.13192.

42.

Imaging biomarker roadmap for cancer studies.

O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC.

Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. doi: 10.1038/nrclinonc.2016.162. Epub 2016 Oct 11. Review.

43.

Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Kleibeuker EA, Fokas E, Allen PD, Kersemans V, Griffioen AW, Beech J, Im JH, Smart SC, Castricum KC, van den Berg J, Schulkens IA, Hill SA, Harris AL, Slotman BJ, Verheul HM, Muschel RJ, Thijssen VL.

Oncotarget. 2016 Nov 22;7(47):76613-76627. doi: 10.18632/oncotarget.12814.

44.

Postpartum Health Information Seeking Using Mobile Phones: Experiences of Low-Income Mothers.

Guerra-Reyes L, Christie VM, Prabhakar A, Harris AL, Siek KA.

Matern Child Health J. 2016 Nov;20(Suppl 1):13-21.

45.

Imaging oligometastatic cancer before local treatment.

Franklin JM, Sharma RA, Harris AL, Gleeson FV.

Lancet Oncol. 2016 Sep;17(9):e406-14. doi: 10.1016/S1470-2045(16)30277-7. Epub 2016 Aug 30. Review.

PMID:
27599145
46.

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

Harjes U, Bridges E, Gharpure KM, Roxanis I, Sheldon H, Miranda F, Mangala LS, Pradeep S, Lopez-Berestein G, Ahmed A, Fielding B, Sood AK, Harris AL.

Oncogene. 2017 Feb 16;36(7):912-921. doi: 10.1038/onc.2016.256. Epub 2016 Aug 29.

47.

The Role of pH Regulation in Cancer Progression.

McIntyre A, Harris AL.

Recent Results Cancer Res. 2016;207:93-134. doi: 10.1007/978-3-319-42118-6_5. Review.

PMID:
27557536
48.

Cervical Cancer Screening for Women Living with HIV.

Chapman CL, Harris AL.

Nurs Womens Health. 2016 Aug-Sep;20(4):392-8. doi: 10.1016/j.nwh.2016.07.002. Review.

PMID:
27520603
49.

Normal tissue radioprotection by amifostine via Warburg-type effects.

Koukourakis MI, Giatromanolaki A, Zois CE, Kalamida D, Pouliliou S, Karagounis IV, Yeh TL, Abboud MI, Claridge TD, Schofield CJ, Sivridis E, Simopoulos C, Tokmakidis SP, Harris AL.

Sci Rep. 2016 Aug 10;6:30986. doi: 10.1038/srep30986.

50.

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment.

Mehta S, Hughes NP, Li S, Jubb A, Adams R, Lord S, Koumakis L, van Stiphout R, Padhani A, Makris A, Buffa FM, Harris AL.

EBioMedicine. 2016 Aug;10:109-16. doi: 10.1016/j.ebiom.2016.07.017. Epub 2016 Jul 16.

Supplemental Content

Loading ...
Support Center